|
Market Closed -
Toronto S.E.
08:00:00 04/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 4.230 CAD | -5.37% |
|
-7.44% | -12.24% |
| 04/11 | HLS Partners With Bayer to Sell Heart Failure Medication in Canada | MT |
| 01/10 | HLS Therapeutics Inc. Announces Board and Committee Changes | CI |
| Market Cap | 92M 82.2M 75.5M 68.57M 129M 8.72B 132M 901M 363M 4.6B 345M 338M 14.58B | P/E 2026 * |
-14.6x | P/E 2027 * | -43.2x |
|---|---|---|---|---|---|
| Enterprise Value | 92M 82.2M 75.5M 68.57M 129M 8.72B 132M 901M 363M 4.6B 345M 338M 14.58B | EV / Sales 2026 * |
1.58x | EV / Sales 2027 * | 1.41x |
| Free-Float |
99.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HLS | Delayed | |
Deutsche Boerse AG
| 74D | Delayed |
Last Transcript: HLS Therapeutics Inc.
| 1 day | -5.37% | ||
| 1 week | -7.44% | ||
| Current month | -6.21% | ||
| 1 month | +9.30% | ||
| 3 months | +0.71% | ||
| 6 months | -9.03% | ||
| Current year | -12.24% |
| 1 week | 4.2 |  | 4.69 |
| 1 month | 3.9 | | 4.69 |
| Current year | 3.56 | | 5.25 |
| 1 year | 3.56 | | 5.44 |
| 3 years | 3 | | 5.76 |
| 5 years | 3 | | 18.9 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 01/05/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 26/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 12/03/2018 |
John Welborn
CHM | Chairman | 48 | 22/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/26 | Tax | Company | 1,000 | 0.0032% | - | |
| 30/9/26 | Tax | Company | -1,000 | 0.0032% | - | |
| 29/9/26 | Tax | Company | 2,000 | 0.0065% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.37% | -7.44% | -23.09% | -14.55% | 92M | |
| -0.11% | +9.94% | +57.20% | +148.21% | 1,255B | |
| -1.62% | -0.95% | +42.90% | +75.88% | 641B | |
| -0.98% | -0.14% | +34.93% | +102.23% | 505B | |
| +0.68% | -1.25% | +49.17% | +66.06% | 381B | |
| -2.49% | +2.01% | +75.38% | +39.94% | 357B | |
| +1.57% | +3.44% | +31.71% | +58.67% | 303B | |
| +1.49% | +9.59% | +11.65% | +36.12% | 286B | |
| -0.90% | +2.97% | +55.67% | +70.93% | 249B | |
| -1.68% | +5.27% | +37.21% | +105.26% | 208B | |
| Average | +1.14% | +1.91% | +37.27% | +68.87% | 418.53B | |
| Weighted average by Cap. | +2.14% | +3.90% | +47.10% | +94.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.34M 52.12M 47.87M 43.48M 81.65M 5.53B 83.7M 571M 230M 2.92B 219M 214M 9.24B | 65.06M 58.12M 53.39M 48.49M 91.06M 6.16B 93.35M 637M 256M 3.25B 244M 239M 10.31B |
| Net income | -5.47M -4.89M -4.49M -4.08M -7.66M -518M -7.85M -53.58M -21.55M -273M -20.53M -20.09M -867M | -2.16M -1.93M -1.78M -1.61M -3.03M -205M -3.11M -21.2M -8.53M -108M -8.12M -7.95M -343M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/11/26 | CAD 4.230 | -5.37% | 56,660 |
| 02/11/26 | CAD 4.470 | -0.89% | 10,905 |
| 30/10/26 | CAD 4.510 | -1.10% | 35,743 |
| 29/10/26 | CAD 4.560 | 0.00% | 158,109 |
| 28/10/26 | CAD 4.560 | -0.22% | 11,532 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
